205 related articles for article (PubMed ID: 23875016)
1. Genes dysregulated to different extent or oppositely in estrogen receptor-positive and estrogen receptor-negative breast cancers.
Zhou X; Shi T; Li B; Zhang Y; Shen X; Li H; Hong G; Liu C; Guo Z
PLoS One; 2013; 8(7):e70017. PubMed ID: 23875016
[TBL] [Abstract][Full Text] [Related]
2. EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer.
Katsyv I; Wang M; Song WM; Zhou X; Zhao Y; Park S; Zhu J; Zhang B; Irie HY
Oncotarget; 2016 Oct; 7(43):69592-69605. PubMed ID: 27612429
[TBL] [Abstract][Full Text] [Related]
3. Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers.
Manzano RG; Martinez-Navarro EM; Forteza J; Brugarolas A
Int J Oncol; 2014 Dec; 45(6):2250-66. PubMed ID: 25201346
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.
Alles MC; Gardiner-Garden M; Nott DJ; Wang Y; Foekens JA; Sutherland RL; Musgrove EA; Ormandy CJ
PLoS One; 2009; 4(3):e4710. PubMed ID: 19270750
[TBL] [Abstract][Full Text] [Related]
6. mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer.
Cheng C; Fu X; Alves P; Gerstein M
Genome Biol; 2009; 10(9):R90. PubMed ID: 19723326
[TBL] [Abstract][Full Text] [Related]
7. Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells.
Lin CY; Ström A; Vega VB; Kong SL; Yeo AL; Thomsen JS; Chan WC; Doray B; Bangarusamy DK; Ramasamy A; Vergara LA; Tang S; Chong A; Bajic VB; Miller LD; Gustafsson JA; Liu ET
Genome Biol; 2004; 5(9):R66. PubMed ID: 15345050
[TBL] [Abstract][Full Text] [Related]
8. The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer.
Calaluce R; Gubin MM; Davis JW; Magee JD; Chen J; Kuwano Y; Gorospe M; Atasoy U
BMC Cancer; 2010 Apr; 10():126. PubMed ID: 20370918
[TBL] [Abstract][Full Text] [Related]
9. Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.
Bianchini G; Qi Y; Alvarez RH; Iwamoto T; Coutant C; Ibrahim NK; Valero V; Cristofanilli M; Green MC; Radvanyi L; Hatzis C; Hortobagyi GN; Andre F; Gianni L; Symmans WF; Pusztai L
J Clin Oncol; 2010 Oct; 28(28):4316-23. PubMed ID: 20805453
[TBL] [Abstract][Full Text] [Related]
10. Lipid metabolism genes in contralateral unaffected breast and estrogen receptor status of breast cancer.
Wang J; Scholtens D; Holko M; Ivancic D; Lee O; Hu H; Chatterton RT; Sullivan ME; Hansen N; Bethke K; Zalles CM; Khan SA
Cancer Prev Res (Phila); 2013 Apr; 6(4):321-30. PubMed ID: 23512947
[TBL] [Abstract][Full Text] [Related]
11. Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.
Yau C; Benz CC
Breast Cancer Res; 2008; 10(4):R61. PubMed ID: 18631401
[TBL] [Abstract][Full Text] [Related]
12. Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas.
Bjørklund SS; Kristensen VN; Seiler M; Kumar S; Alnæs GI; Ming Y; Kerrigan J; Naume B; Sachidanandam R; Bhanot G; Børresen-Dale AL; Ganesan S
BMC Cancer; 2015 Jul; 15():524. PubMed ID: 26183823
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype.
Hefti MM; Hu R; Knoblauch NW; Collins LC; Haibe-Kains B; Tamimi RM; Beck AH
Breast Cancer Res; 2013; 15(4):R68. PubMed ID: 23971947
[TBL] [Abstract][Full Text] [Related]
14. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.
Ghosh MG; Thompson DA; Weigel RJ
Cancer Res; 2000 Nov; 60(22):6367-75. PubMed ID: 11103799
[TBL] [Abstract][Full Text] [Related]
15. Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.
Iwamoto T; Bianchini G; Booser D; Qi Y; Coutant C; Shiang CY; Santarpia L; Matsuoka J; Hortobagyi GN; Symmans WF; Holmes FA; O'Shaughnessy J; Hellerstedt B; Pippen J; Andre F; Simon R; Pusztai L
J Natl Cancer Inst; 2011 Feb; 103(3):264-72. PubMed ID: 21191116
[TBL] [Abstract][Full Text] [Related]
16. Genome-Wide Transcriptome Analysis of Estrogen Receptor-Positive and Human Epithelial Growth Factor Receptor 2-Positive Breast Cancers by Ribonucleic Acid Sequencing.
Chen P; Song W; Liu L
Gynecol Obstet Invest; 2018; 83(4):338-348. PubMed ID: 29241203
[TBL] [Abstract][Full Text] [Related]
17. During hormone depletion or tamoxifen treatment of breast cancer cells the estrogen receptor apoprotein supports cell cycling through the retinoic acid receptor α1 apoprotein.
Salazar MD; Ratnam M; Patki M; Kisovic I; Trumbly R; Iman M; Ratnam M
Breast Cancer Res; 2011 Feb; 13(1):R18. PubMed ID: 21299862
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
[TBL] [Abstract][Full Text] [Related]
19. Distinct genes related to drug response identified in ER positive and ER negative breast cancer cell lines.
Shen K; Rice SD; Gingrich DA; Wang D; Mi Z; Tian C; Ding Z; Brower SL; Ervin PR; Gabrin MJ; Tseng G; Song N
PLoS One; 2012; 7(7):e40900. PubMed ID: 22815861
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation.
Smith DD; Saetrom P; Snøve O; Lundberg C; Rivas GE; Glackin C; Larson GP
BMC Bioinformatics; 2008 Jan; 9():63. PubMed ID: 18226260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
